세계의 심혈관 디지털 헬스 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global Digital Health For Cardiovascular Market size is anticipated to grow from USD 100.56 Billion in 2024 to USD 172.42 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period of 2026 to 2033.

The digital health for cardiovascular market is experiencing significant growth , driven by the increasing prevalence of cardiovascular diseases and the rising demand for innovative healthcare solutions. Digital health technologies, including mobile health applications, wearable devices, and telehealth services, are transforming the way cardiovascular care is delivered. These solutions enable patients to monitor their heart health, track vital signs, and communicate with healthcare providers in real-time, leading to improved patient outcomes and enhanced disease management. As awareness of cardiovascular health grows and the need for accessible healthcare solutions increases, the demand for digital health technologies in this sector is expected to rise, positioning this market for robust expansion.

Moreover, advancements in data analytics and artificial intelligence are propelling innovation within the digital health for cardiovascular market. The integration of predictive analytics and machine learning algorithms allows for more personalized treatment plans and proactive interventions, enhancing the overall effectiveness of cardiovascular care. These innovations not only improve patient engagement but also facilitate better decision-making for healthcare providers. As research continues to explore new applications and technologies in digital health, the market is likely to expand further, driven by the promise of improved health outcomes and patient satisfaction.

Additionally, the growing emphasis on preventive care and remote monitoring is shaping the digital health for cardiovascular landscape. As healthcare systems increasingly prioritize early detection and management of cardiovascular conditions, the demand for digital health solutions that support preventive care is likely to increase. This trend is particularly relevant in the context of chronic disease management, where continuous monitoring and timely interventions can significantly impact patient health. As the digital health for cardiovascular market continues to evolve, the combination of technological advancements, a focus on preventive care, and the need for effective health management solutions will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Component

• Software
• Hardware
• Services

By End-use

• Patients
• Providers
• Payers
• Others
• COMPANIES PROFILED
• Orange Business
• GE Healthcare
• Health Information Management Systems (HIMS)
• Apple Inc.
• Siemens Healthineers AG
• Oracle (Cerner Corporation)
• NXGN Management LLC
• Samsung
• Doven
• CardiAI
• AliveCor Inc.
• Verily Life Sciences LLC
• HeartFlow Inc.
• Bardy Diagnostics Inc.
• Vista AI
• Viz Ai
• RSIP Vision
• Cleerly Inc./ taken by our site
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. DIGITAL HEALTH FOR CARDIOVASCULAR INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Technology
  • 3.7.2 Market Attractiveness Analysis By Product Type
  • 3.7.3 Market Attractiveness Analysis By Deployment
  • 3.7.4 Market Attractiveness Analysis By Application
  • 3.7.5 Market Attractiveness Analysis By End User
  • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY TECHNOLOGY

• 5.1. Overview By Technology
• 5.2. Historical and Forecast Data Analysis By Technology
• 5.3. Artificial Intelligence (AI) Historic and Forecast Sales By Regions
• 5.4. Internet of Things (IoT) Historic and Forecast Sales By Regions
• 5.5. Telemedicine Historic and Forecast Sales By Regions
• 5.6. Wearable Devices Historic and Forecast Sales By Regions
• 5.7. Big Data Analytics Historic and Forecast Sales By Regions
• 5.8. Blockchain Historic and Forecast Sales By Regions

6. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY PRODUCT TYPE

• 6.1. Overview By Product Type
• 6.2. Historical and Forecast Data Analysis By Product Type
• 6.3. Remote Monitoring Devices Historic and Forecast Sales By Regions
• 6.4. Mobile Health Applications Historic and Forecast Sales By Regions
• 6.5. Diagnostic Software Historic and Forecast Sales By Regions
• 6.6. Wearable ECG Monitors Historic and Forecast Sales By Regions
• 6.7. Blood Pressure Monitors Historic and Forecast Sales By Regions
• 6.8. Biosensors Historic and Forecast Sales By Regions

7. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY DEPLOYMENT

• 7.1. Overview By Deployment
• 7.2. Historical and Forecast Data Analysis By Deployment
• 7.3. On-Premise Historic and Forecast Sales By Regions
• 7.4. Cloud Historic and Forecast Sales By Regions

8. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY APPLICATION

• 8.1. Overview By Application
• 8.2. Historical and Forecast Data Analysis By Application
• 8.3. Cardiac Monitoring Historic and Forecast Sales By Regions
• 8.4. Diagnosis and Early Detection Historic and Forecast Sales By Regions
• 8.5. Post-Surgical Care Historic and Forecast Sales By Regions
• 8.6. Preventive Care Historic and Forecast Sales By Regions
• 8.7. Rehabilitation Management Historic and Forecast Sales By Regions

9. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY END USER

• 9.1. Overview By End User
• 9.2. Historical and Forecast Data Analysis By End User
• 9.3. Hospitals and Clinics Historic and Forecast Sales By Regions
• 9.4. Homecare Settings Historic and Forecast Sales By Regions
• 9.5. Ambulatory Care Centers Historic and Forecast Sales By Regions
• 9.6. Academic and Research Institutes Historic and Forecast Sales By Regions

10. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.3.2 North America By Segment Sales Analysis
  • 10.3.3 North America By Country Sales Analysis
  • 10.3.4 United States Sales Analysis
  • 10.3.5 Canada Sales Analysis
  • 10.3.6 Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.4.2 Europe By Segment Sales Analysis
  • 10.4.3 Europe By Country Sales Analysis
  • 10.4.4 United Kingdom Sales Analysis
  • 10.4.5 France Sales Analysis
  • 10.4.6 Germany Sales Analysis
  • 10.4.7 Italy Sales Analysis
  • 10.4.8 Russia Sales Analysis
  • 10.4.9 Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.5.2 Asia Pacific By Segment Sales Analysis
  • 10.5.3 Asia Pacific By Country Sales Analysis
  • 10.5.4 China Sales Analysis
  • 10.5.5 India Sales Analysis
  • 10.5.6 Japan Sales Analysis
  • 10.5.7 South Korea Sales Analysis
  • 10.5.8 Australia Sales Analysis
  • 10.5.9 South East Asia Sales Analysis
  • 10.5.10 Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.6.2 Latin America By Segment Sales Analysis
  • 10.6.3 Latin America By Country Sales Analysis
  • 10.6.4 Brazil Sales Analysis
  • 10.6.5 Argentina Sales Analysis
  • 10.6.6 Peru Sales Analysis
  • 10.6.7 Chile Sales Analysis
  • 10.6.8 Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.7.2 Middle East & Africa By Segment Sales Analysis
  • 10.7.3 Middle East & Africa By Country Sales Analysis
  • 10.7.4 Saudi Arabia Sales Analysis
  • 10.7.5 UAE Sales Analysis
  • 10.7.6 Israel Sales Analysis
  • 10.7.7 South Africa Sales Analysis
  • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE DIGITAL HEALTH FOR CARDIOVASCULAR COMPANIES

• 11.1. Digital Health for Cardiovascular Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12. COMPANY PROFILES OF DIGITAL HEALTH FOR CARDIOVASCULAR INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Market Concentration Rate
• 12.3. AliveCor
  • 12.3.1 Company Overview
  • 12.3.2 Company Revenue
  • 12.3.3 Products
  • 12.3.4 Recent Developments
• 12.4. HeartFlow Inc.
  • 12.4.1 Company Overview
  • 12.4.2 Company Revenue
  • 12.4.3 Products
  • 12.4.4 Recent Developments
• 12.5. Biotronik
  • 12.5.1 Company Overview
  • 12.5.2 Company Revenue
  • 12.5.3 Products
  • 12.5.4 Recent Developments
• 12.6. Boston Scientific Corporation
  • 12.6.1 Company Overview
  • 12.6.2 Company Revenue
  • 12.6.3 Products
  • 12.6.4 Recent Developments
• 12.7. Medtronic
  • 12.7.1 Company Overview
  • 12.7.2 Company Revenue
  • 12.7.3 Products
  • 12.7.4 Recent Developments
• 12.8. Abbott Laboratories
  • 12.8.1 Company Overview
  • 12.8.2 Company Revenue
  • 12.8.3 Products
  • 12.8.4 Recent Developments
• 12.9. GE Healthcare
  • 12.9.1 Company Overview
  • 12.9.2 Company Revenue
  • 12.9.3 Products
  • 12.9.4 Recent Developments
• 12.10. Philips Healthcare
  • 12.10.1 Company Overview
  • 12.10.2 Company Revenue
  • 12.10.3 Products
  • 12.10.4 Recent Developments
• 12.11. Siemens Healthineers
  • 12.11.1 Company Overview
  • 12.11.2 Company Revenue
  • 12.11.3 Products
  • 12.11.4 Recent Developments
• 12.12. Edwards Lifesciences
  • 12.12.1 Company Overview
  • 12.12.2 Company Revenue
  • 12.12.3 Products
  • 12.12.4 Recent Developments
• 12.13. Cardinal Health
  • 12.13.1 Company Overview
  • 12.13.2 Company Revenue
  • 12.13.3 Products
  • 12.13.4 Recent Developments
• 12.14. LivaNova PLC
  • 12.14.1 Company Overview
  • 12.14.2 Company Revenue
  • 12.14.3 Products
  • 12.14.4 Recent Developments
• 12.15. FibriCheck
  • 12.15.1 Company Overview
  • 12.15.2 Company Revenue
  • 12.15.3 Products
  • 12.15.4 Recent Developments
• 12.16. Aktiia
  • 12.16.1 Company Overview
  • 12.16.2 Company Revenue
  • 12.16.3 Products
  • 12.16.4 Recent Developments
• 12.17. HD Medical
  • 12.17.1 Company Overview
  • 12.17.2 Company Revenue
  • 12.17.3 Products
  • 12.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies